Quality by Design-Based Optimization and Validation of a High-Performance Thin-Layer Chromatography Method for the Estimation of Rivaroxaban in Bulk and Its Pharmaceutical Dosage Form
Author:
Affiliation:
1. Department of Pharmaceutical Chemistry, Sinhgad Technical Education Society Sinhgad Institute of Pharmacy, Narhe, Pune 411041, Maharashtra, India.
Publisher
Akademiai Kiado Zrt.
Subject
Clinical Biochemistry,Biochemistry,Analytical Chemistry
Link
https://www.akademiai.com/doi/pdf/10.1556/1006.2019.32.6.9
Reference10 articles.
1. Rivaroxaban: A New Oral Factor Xa Inhibitor
2. Discovery of the Novel Antithrombotic Agent 5-Chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Quality by Design in Pharmaceutical Development: Current Advances and Future Prospects;Software and Programming Tools in Pharmaceutical Research;2024-03-19
2. ICH and US-FDA validated HPTLC methods with greenness assessments for the assay of mixtures prescribed in stroke prophylaxis: application to pharmaceutical preparations and human plasma;JPC – Journal of Planar Chromatography – Modern TLC;2022-11
3. Application of the Life Cycle Management of Analytical methods concept to a HPTLC-DPPH assay method for acteoside content in industrial extracts of Plantago lanceolata L;Journal of Chromatography B;2021-09
4. A review on: analysis of the first oral, direct factor Xa inhibitor; Rivaroxaban;Microchemical Journal;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3